Transplantation of amniotic membrane and limbal autograft in the treatment of recurrent pterygium

E. Hatano, J. Shimazaki, Kazuo Tsubota

Research output: Contribution to journalArticle

Abstract

We surgically treated recurrent pterygium in two eyes of two patients aged 63 and 67 years. Both eyes showed symblepharon and restricted abduction. After excising the pterygium and separating the symblepharon, the bared sclera was covered by preserved amniotic membrane. This area was further covered by a piece of bulbar conjunctiva from the same eye. The amnion was used, as the rationale, because of its antiinflammatory effect, inhibition of neovascularization and absence of antigenicity. There was no recurrence after surgery. The ocular motility became normalized. The present surgical approach was thus useful in treating recurrent pterygium.

Original languageEnglish
Pages (from-to)1101-1104
Number of pages4
JournalJapanese Journal of Clinical Ophthalmology
Volume50
Issue number6
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Pterygium
Amnion
Autografts
Transplantation
Sclera
Conjunctiva
Therapeutics
Anti-Inflammatory Agents
Recurrence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Transplantation of amniotic membrane and limbal autograft in the treatment of recurrent pterygium. / Hatano, E.; Shimazaki, J.; Tsubota, Kazuo.

In: Japanese Journal of Clinical Ophthalmology, Vol. 50, No. 6, 1996, p. 1101-1104.

Research output: Contribution to journalArticle

@article{ea1b46be040144ccb10b80f9327d14ff,
title = "Transplantation of amniotic membrane and limbal autograft in the treatment of recurrent pterygium",
abstract = "We surgically treated recurrent pterygium in two eyes of two patients aged 63 and 67 years. Both eyes showed symblepharon and restricted abduction. After excising the pterygium and separating the symblepharon, the bared sclera was covered by preserved amniotic membrane. This area was further covered by a piece of bulbar conjunctiva from the same eye. The amnion was used, as the rationale, because of its antiinflammatory effect, inhibition of neovascularization and absence of antigenicity. There was no recurrence after surgery. The ocular motility became normalized. The present surgical approach was thus useful in treating recurrent pterygium.",
author = "E. Hatano and J. Shimazaki and Kazuo Tsubota",
year = "1996",
language = "English",
volume = "50",
pages = "1101--1104",
journal = "Japanese Journal of Clinical Ophthalmology",
issn = "0370-5579",
publisher = "Igaku-Shoin Ltd",
number = "6",

}

TY - JOUR

T1 - Transplantation of amniotic membrane and limbal autograft in the treatment of recurrent pterygium

AU - Hatano, E.

AU - Shimazaki, J.

AU - Tsubota, Kazuo

PY - 1996

Y1 - 1996

N2 - We surgically treated recurrent pterygium in two eyes of two patients aged 63 and 67 years. Both eyes showed symblepharon and restricted abduction. After excising the pterygium and separating the symblepharon, the bared sclera was covered by preserved amniotic membrane. This area was further covered by a piece of bulbar conjunctiva from the same eye. The amnion was used, as the rationale, because of its antiinflammatory effect, inhibition of neovascularization and absence of antigenicity. There was no recurrence after surgery. The ocular motility became normalized. The present surgical approach was thus useful in treating recurrent pterygium.

AB - We surgically treated recurrent pterygium in two eyes of two patients aged 63 and 67 years. Both eyes showed symblepharon and restricted abduction. After excising the pterygium and separating the symblepharon, the bared sclera was covered by preserved amniotic membrane. This area was further covered by a piece of bulbar conjunctiva from the same eye. The amnion was used, as the rationale, because of its antiinflammatory effect, inhibition of neovascularization and absence of antigenicity. There was no recurrence after surgery. The ocular motility became normalized. The present surgical approach was thus useful in treating recurrent pterygium.

UR - http://www.scopus.com/inward/record.url?scp=0029979804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029979804&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029979804

VL - 50

SP - 1101

EP - 1104

JO - Japanese Journal of Clinical Ophthalmology

JF - Japanese Journal of Clinical Ophthalmology

SN - 0370-5579

IS - 6

ER -